Financial News
Latest News about SNY
Recent news which mentions SNY
From Benzinga
From Benzinga
GSK and Sanofi shares surge after Florida ruling dismisses Zantac lawsuits in what one analyst describes as ‘best-case scenario’
December 07, 2022
From MarketWatch
These 3 Stocks Escaped Tuesday's Market Downdraft
December 06, 2022
From Motley Fool
Why GSK Plc And Sanofi SA Stock Are Shooting Higher
December 06, 2022
From Benzinga
From Benzinga
The S&P 500 is on the cusp of breaking through a level that might spell the end of the bear market
December 01, 2022
From MarketWatch
Why Horizon Therapeutics Stock Is Skyrocketing Today
November 30, 2022
From Motley Fool
Why Is Horizon Therapeutics (HZNP) Stock Up 30% Today?
November 30, 2022
From InvestorPlace
From Motley Fool
UK Drug Regulator Warns Of Severe Eye Reactions Associated With Sanofi/Regeneron's Dupixent
November 30, 2022
From Benzinga
From Benzinga
Horizon Therapeutics Shares Jump On Confirmation Of Takeover Talks With Several Large Companies
November 30, 2022
From Benzinga
First Drug That Can Delay Onset of Type 1 Diabetes Gets FDA Approval After Multiple Regulatory Hurdles
November 18, 2022
From Benzinga
Europe Approves Sanofi's Enjaymo For Rare Form Of Anemia
November 17, 2022
Tickers
SNY
From Benzinga
Can This Company's Research Help Transform Regenerative Medicine As Its Lead Product Receives FDA IND Approval?
November 14, 2022
From Benzinga
2 Top Biotech Stocks to Buy in November
November 12, 2022
From Motley Fool
Europe Approves Sanofi, GSK's Beta Variant Adapted COVID Shot As Booster
November 10, 2022
From Benzinga
Europe Approves AstraZeneca-Sanofi Partnered Antibody To Prevent RSV Infection In Infants
November 04, 2022
From Benzinga
Why Is Provention Biosciences (PRVB) Stock Up 25% Today?
November 03, 2022
From InvestorPlace
From Benzinga
Earnings Scheduled For October 28, 2022
October 28, 2022
From Benzinga
Tickers
SNY
From MarketWatch
From Motley Fool
US Stock Futures Lower Following Friday's Rally; Tesla In Focus
October 24, 2022
From Benzinga
New Drugs Approvals Bring No Relief for Ailing Innovent Bio
October 18, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
